Imagini ale paginilor
PDF
ePub
[merged small][merged small][merged small][ocr errors]
[merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][ocr errors]

མཔས་

Kleinman, JE-6

Kafka MS, van Kammen DP and Klelaman JE The alpha adrenergic receptor
in marc Normal function and pathology. In: Neuroreceptors-Basic and Clinical
Aspects. Usdin E, Bunney WE Jr. and Davis JM (eds.) John Wiley and Sons,
-England, 1981, pp. 129-139.

[blocks in formation]

Aulakh GS, Kleinman JE, Aulakh HS, Albrecht P, Torrey EF and Wyatt RJ:
Search for cytomegalovirus in schizophrenic brain tissue. Proc Soc Exp Bio Med
167:172-174, 1981.

Wyatt RJ, Moja EA, Karoumn F, Stoff DM, Potkin SG and Kleinman JE
Phenylethylamine, dopamine and norepinephrine in schizophrenia.

Inc Apormorphine and Other Dopaminomimetics. Raven Press, New York,
1981, pp. 39-44.

Potkin SG, Weinberger D, Kleinman JE, Bigelow L, Bjornsson TD, Gillm JC,
Nasrallah H, Luchins D, Fischer SH, Linnoila M, Carman J and Wyatt RJ:
Wheat gluten challenge in schizophrenic patients. Am J Psychiatry
138:1208-1211, 1981.

Lackovic Z, Kleinman JE, Karoum F and Neff NH: Dopamine and its
metabolites in human peripheral nerves. Is there a widely distributed
system of peripheral dopaminergic nerves? Life Sci 29.917-922, 1981.

Freed WJ, Karson CN, Kleinman JE and Wyatt RJ: Increased spontaneous
eye-blinks in cerebellectomized rats. Biol Psychiatry 16:789-793, 1981.

Kafia MS, van Kammen DP, Kleinman JE, Nurnberger Jl, Siever LJ, Uhde TW
and Polinsky RJ: Alpha-adrenergic receptor in schizophrenia, affective disorders
and some neurologial diseases. Comm Psychopharmacol 4:477-486, 1981.

Karson CN, Berman KF, Donnelly EF, Mendelson WB, Kleinman JE

and Wyatt RJ: Speaking, thinking and blinking. Esychiatry hes 5243-246, 1981.

[blocks in formation]

CONFIDENTIAL

[blocks in formation]

Wyatt Rd, Karoum F, Stoff DM, Kleinman JE, GMlm JC, Jeste DV
and Potkin SG: Monoamine oxidase, phenylethylamine, norepinephrine
and schizophrenia. Clin Genetics 19:437–442, 1981.

Jeste DV, Kleinman JE, Luchins DJ, Potkin SG and Weinberger DR:
Ex uno multi: Subtyping the schizophrenic syndrome. Biol Psychiatry
17:199-222, 1982

Kleinman JE, Karoum F, Rosenblatt JE, Gillin JC, Hong JH, Bridge TP,
Zalcman S, Storch F, Carmen R and Wyatt Rd: Postmortem neurochemical
studies in chronic schizophrenia. In: Biological Markers In Psychiatry and
Neurology, Hanin I and Usdin E (eds.). Oxford and Pergamon Press,
New York, 1982, pp. 67-76.

Karson CN, Kleinman JE, Freed WJ, Bigelow LB, Weinberger DR and
Wyatt Rut: Blink rates in schizophrenia, la: Biological Markers in Psychiatry
and Neurology, Hanin I and Usɗin E (eds.). Oxford and New York, Pergamon
Press, 1982, pp. 339-345.

Kafka MS, van Kammen DP and Kleinman JE: Alpha-adrenergic function in
schizophrenia, affective disorders and some disease of neural transmission.
lac Biological Psychiatry 1981 Developments in Psychiatry, Volume 5.
Perris C, Struwe G and Jansson B (eds.). Bsevier, North-Holland, Amsterdam,
1982, pp. 691-694.

Kleinman JE, Karoum F, Rosenblatt JE, Gällin JC, Hong J, Bridge TP,
Zalcman S, Storch F, Carmen R and Wyatt R.: Catecholamines and peptides
in postmortem schizophrenic brains. La Developments in Psychiatry. Volume 5.
Perris C, Struwe G and Jansson 8 (eds.): Biologicals Psychiatry 1981 Elsevier,
North Holland, Amsterdam, 1982, pp. 711-714.

Wyatt RJ, Cutler NR, DeLisi LE, Jeste DV, Kleinman JE, Lochins DJ, Potkin SG
and Weinberger DR: Chapter. Biochemical and morphological factors in the
etiology of the schizophrenic disorders. In: The American Psychiatric Association
Annual Review, Grinspoon L (ed). APA Press 1982, Washington D.C.,
pp. 1112-153.

DeLisi LE, Freed WJ, Gillin JC, Kleinman JE, Bigelow LB and Wyatt RJ:
P-chlorophenylalanine trials in schizophrenic patients. Biol Psychiatry
17:471-477, 1982

Kleinman JE, Weinberger DR, Rogol AD, Bigelow LB, Klein ST, Gillin JC and
Wyatt RJ: Relationships between plasma prolactin concentrations and
psychopathology in chronic schizophrenia. Arch Gen Psychiatry 39:655-657, 1982.

Karson CN, Bigelow LB, Kleinman JE, Weinberger DR and Wyatt R.: Haloperidol
induced changes in blink rates correlate with changes in BPRS score.

Br J Psychiatry 140-503-507, 1982

008

[blocks in formation]

CONFIDENTIAL

43)

44)

45)

46)

48)

49)

50)

51)

·

52)

53)

54)

55)

Kleinman JE, Weinberger DR, Rogol A Shiling DJ, Mendelson WB and
Wyatt RJ: Naloxone in chronic schizophrenic patients: Neuroendocrine
and behavioral effects. Psychiatry Res 7:1-7, 1982.

Jeste DV, Zalcman S, Weinberger DR, Cutler NR, Bigelow LB, Kleinman JE,
Rogol A, Gălin JC and Wyatt RC Apomorphine response and subtyping of
schizohrenia. Prog Neuro-Psychopharmacol and Biol Psychiatry 7-83-88, 1983.

Karson CN, Kleinman JE, Berman KF, Phelps BH, Wise CD, DeLisi LE and
Jeste DV: An inverse correlation between spontaneous eye-blink rate and
platelet monoamine oxidase activity. Br. J. Psychiatry142-43-46, 1983.

Kleinman JE, ladarola M, Govoni S, Hong J, Gillin JC and Wyatt RJ:
Postmortem measurements of neuropeptides in human brain.
Psychopharmacology Bull 19:375-377, 1983.

Memo M, Kleinman JE and Hanbauer L: Coupling of dopamine D1
recognition sites with adenylate cyclase in nuclei accumbens and caudatus
of schizophrenics. Science 221.1304-107, 1983.

Karson CN, Berman KF, Kleinman JE and Wyatt RJ: Seasonal variation in
human central dopamine activity. Psychiatry Res 11.111-117, 1984.

Korpi ER, Kleinman JE, Costakos DT, Linnoïla M and Wyatt RJ: Reduced
haloperidol in the postmortem brains of haloperidol treated patients.
Psychiatry Res. 11-259-269, 1984.

Kleinman JE Catecholamines in the brains of schizophrenic patients.
Inc Racagni G, Paoletti R and Kielholz P (eds.): Clinical Neuropharmacology.
Vol 7. Raven Press, New York, 1984.

Kaufmann CA, Galin JC, Hill B, OʻLaughĩa T, Phillips (, Kleinman JE and
Wyatt RJ: Muscarinic binding in suicides. Psychiatry Res 1247-55, 1984.

Bracha HS and Kleinman JE: Post-mortem studies in psychiatry.
Psychiatric Clinics of North America 7:473-485, 1984.

Kleinman JE, Karson CN, Weinberger DR, Freed WJ, Berman KF and
Wyatt Rt Eye-blinking and cerebral ventricular size in chronic schizophrenic
patients. Am J Psychiatry 141:1430-1432, 1984.

Kleinman JE, Reid A, Lake CR and Wyatt RJ: Chapter 14: Studies of
norepinephrine in schizophrenia. In: The Catecholamines and Neurologic
Disorders. Lake CR and Ziegler MG (eds.). Butterworth Publishers, Boston,
Massachusetts, 1985, pp. 285-311.

Kleinman JE, Hong J, ladarola M, Govoni S and Gillin JC: Neuropeptides in
human brains-postmortem studies. Prog. In Neuro Psychopharmacol and
Biol Psychiatry, 9:91-96, 1985.

[blocks in formation]

CONFIDENTIAL

[blocks in formation]

Bridge TP, Kleinman JE, Karoum F and Wyatt RJ: Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls. Neuropsychobiology 14:53-56, 1985.

Hanbauer I, Memo M and Kleinman JE Increased efficiency in the coupling of dopamine-D-1 recognition sites with adenylate cyclase in dopamine-rich brain areas of schizophrenics. In: Proceedings of Symposium Schizophrenia: An Integrative View Leibbey J., London, 1985, pp. 159-166.

Weinberger DR and Kleinman JƐ Chapter 3: Observations on the brain in schizophrenia. In: Psychiatry Uodate. The American Psychiatric Association Annual Review Volume 5. Frances AJ and Hales RE (eds.). APA Press 1986, Washington, D.C., pp. 42-67.

Karson CN, Kleinman JE and Wyatt RJ: Chapter 24: Biochemical concepts of schizophrenia. In Contemporary Directions in Psychopathology, Millon T and Klerman G (eds.). The Guilford Press, New York, 1986, pp. 495-518.

Bracha HS and Kleinman JE Postmortem neurochemistry in schizophrenia. Psychiatric Clinics of North America, 9.133-141, 1986.

Kleinman JE: Chapter 15: Postmortem neurochemistry studies in schizophrenia Inc Handbook of Schizophrenia. Volume The Neurology of Schizophrenia · Nasrallah HA and Weinberger DR (eds.). Elsevier Science Publishers, Amsterdam, The Netherlands, 1986, pp. 349-360.

Korpi ER, Kleinman JE, Goodman St, Phillips L, DeLisi LE, Linnolla M and
Wyatt RJ: Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims.
Comparison in chronic schizophrenic patients with suicide as cause of death.
Arch Gen Psychiatry 43-594-600, 1986.

Kafka MS, Kleinman JE, Karson CN and Wyatt R.: Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients. Hillside Journal of Clinical Psychiatry, 8:15-24, 1986.

Ko GN, Unnerstall JR, Kuhar MJ and Kleloman JE: Alpha-2 agonist binding in schizophrenic brains. Psychopharmacology Bull, 22:1011-1016, 1986.

Zelnik N, Angel L, Paul SM and Kelaman JE: Decreased density of human striatal dopamine uptake sites with age. European J Pharmacol 126:175-176, 1986.

Gillin JC, Kelsoe JR Jr., Kaufman CA, Kleiamaa JE, Risch SC and Janowsky DJ: Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder. Annals of the New York Academy of Sciences. 487:143-149, 1986.

Bridge TP, Kleinman JE, Solo BJ and Karoum F: Central catecholamines. cognitive impairment, and affective state in elderly schizophrenics and controls. Biol Psychiatry, 22139-147, 1987.

[blocks in formation]

CONFIDENTIAL

68)

70)

71)

72)

73).

74)

75)

76)

70)

78)

79)

Bracha HS, Shultz C, Glick SD and Kleinman JE: Spontaneous asymmetric circling
behavior in hemi-parkinsonism: A human equivalent of the
lesioned-circling rodent behavior. Life Sci 40:1127-1130, 1987.

Hess EJ, Bracha HS, Kleidman JE and Creese 1: Dopamine receptor subtype
imblance in schizophrenia. Life Sci 40:1487-1497, 1987.

Lake CR, Kleinman JE, Kafka MS, Ko GN, Moore SS and Ziegler M: Chapter &
Norepinephrine metabolism in schizophrenia. In: Handbook of Schizophrenia.
Volume II: Neurochemistry and Neuropharmacology, Nasrallah H and Delisi LE
(eds.). Elsevier Science Publishers, Amsterdam, The Netherlands, 1987,
pp. 227-256.

Kleinman JE, Jaeger A-C, Bracha HS and Fernstrom JD. Left-right
comparisons of neuropeptides in human brain: Preliminary results. la: Cerebral
Dynamics. Laterality and Psychopathology. Developments in Psychiatry
Volume 8: For-Henry P, Takahaski R, Gruzelier J and Niwa S-I (eds.).
Elsevier Science Publishers, Amsterdam, The Netherlands, 1987, pp. 457-462

Janowsky A, Vocci F, Berger P, Angel L, Zelnik N, Kleinman JE, Skolnick P
and Pan SM: [H] GBR-12935 binding to the dopamine transporter is
decreased in the caudate nucleus in Parkinsons's disease. J Neurochem.
49:617-621, 1987.

Korpi ER, Kleinman JE, Goodman St and Wyatt RJ: Neurotransmitter amino
acids in post-mortem brains of chronic schizophrenic patients. Psychiatry Res.
22-291-301, 1987.

Korpi ER, Goodman SL, Kleinman JE and Wyatt RJ: Relationship between
tryptophan and serotonin concentrations in postmortem human brain. Med Biol
65-217-220, 1987.

Rothman RB, Bykov V, Cadet JL and Kleinman JE A postmortern study of
the effect of chronic opiate abuse on psychotomimietic binding sites of human
frontal cortex. Neuropeptides, 10:261-264, 1987.

Korpi ER, Kleiamman JE and Wyatt RJ. GABA concentrations in forebrain areas
of suicide victims. Biol Psychiatry, 23:109-114, 1988.

Kaufmann CA, Weinberger DR, Stevens JR, Asher DM, Kleinman JE, Sulima MP,
Gibbs CJ and Gajdusek DC: Intracerebral inoculation of experimental animals with
brain tissue from patients with schizophrenia. Failure to observe behavioral and
neuropathological effects. Arch Gen Psychiatry 45.648-652, 1988.

Goldberg TE, Kleinman JE, Daniel DG, Myslobodsky MS, Ragland JR and
Weinberger DR: Dementia praecox revisited. Age disorientation, mental status
and ventricular enlargement. Br J Psychiatry, 153:187-190, 1988.

Kleinman JE, Casanova MF and Jaskiw GE: The neuropathology of
schizophrenia Schizophr Bull 14:209-216, 1988.

« ÎnapoiContinuă »